The published clinical trial data on finasteride side effects gives rates and classifications — but it does not tell you what patients actually experience in practice. Here is an honest account based on what is reported by patients who have used the medication.
The majority of patients — approximately 98% in clinical trials — do not experience sexual side effects from finasteride at the 1mg dose used for hair loss. For most men, finasteride is a daily tablet taken with no noticeable effects other than, over months, slower hair loss progression.
In the minority who do experience effects, the most commonly reported are: a modest reduction in libido, some reduction in ejaculatory volume, and in some cases softer erections. These effects are typically mild and, for most patients who experience them, resolve on stopping the medication. The question is whether the benefit — significantly slowed hair loss — justifies the risk of being in the minority who experience these effects.
The post-finasteride syndrome (PFS) literature describes a subset of patients who report persistent sexual and cognitive effects after stopping the medication. This is a recognised concern that regulatory agencies including the MHRA have addressed with updated prescribing information. The prevalence and mechanism remain contested. Patients who are anxious about this possibility may prefer topical finasteride, which achieves comparable scalp DHT reduction with significantly lower systemic drug levels.
The practical recommendation: if you are considering finasteride, discuss the side effect profile with a prescribing physician who can answer your specific questions. Do not make the decision based on forum posts, which systematically overrepresent negative experiences relative to the general user population.
Related reading
